Cargando...
Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre
BACKGROUND: Myasthenia gravis is an autoimmune disease mediated by antibodies against proteins associated with the postsynaptic membrane of the neuromuscular junction. Several drugs may trigger an exacerbation of the disease. Melatonin supplements are widely used for the treatment of insomnia as the...
Gardado en:
| Publicado en: | BMC Neurol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640643/ https://ncbi.nlm.nih.gov/pubmed/33148186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-020-01975-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|